register

News & Trends - Pharmaceuticals

Medicines not mammograms are behind the reduction in breast cancer deaths

Health Industry Hub | June 29, 2020 |

Pharma News: A new Australian systemic review questioned whether population-based mammographic screening or endocrine therapy and chemotherapy (adjuvant therapy) after curative surgery for early or operable breast cancer were associated with the decline in breast cancer mortality.

The decline is breast cancer deaths in the last 20 years can be attributed to the use of therapies such as tamoxifen and chemotherapy, and not to the mammogram screening program, according to an analysis of Victorian women.

The study found that the mammogram screening program did not result in more breast cancer in Victoria being detected at an early rather than an advanced stage, so there was no population mortality benefit. Crude breast cancer mortality declined by 30% after 1994 and the researchers say this was all linked to adjuvant and chemotherapy therapy uptake and not screening.

The authors conclude that BreastScreen should be ceased as persistence with the program may continue to expose women to unnecessary morbidity and mortality.


Medical and Science

Government fails diabetes patients with no implementation or funding plan

Government fails diabetes patients with no implementation or funding plan

Health Industry Hub | November 5, 2024 |

Medical & Science: Ahead of World Diabetes Day on 14 November, A/Professor Sof Andrikopoulos, CEO of the Australian Diabetes Society […]

More


News & Trends - Pharmaceuticals

Government under fire as Senator Ruston slams decision to defer access to new medicines

Government under fire as Senator Ruston slams decision to defer access to new medicines

Health Industry Hub | November 5, 2024 |

Pharma News: Revelations that as many as 44 new medicines are facing months-long delays under the Albanese Government have sparked […]

More


News & Trends - Pharmaceuticals

Patients call for greater transparency of Australia's most common osteoporosis therapy

Patients call for greater transparency of Australia’s most common osteoporosis therapy

Health Industry Hub | November 5, 2024 |

Pharma News: Consumers should be fully informed about the potential side effects of Australia’s most common osteoporosis treatment, according to […]

More


Medical and Science

Digital solutions: Bridging pharma gaps to deliver real impact for patients and clinicians

Digital solutions: Bridging pharma gaps to deliver real impact for patients and clinicians

Health Industry Hub | November 4, 2024 |

Medical & Science: In today’s era of rapid technological advancements, the integration of digital solutions in healthcare offers both transformative […]

More


This content is copyright protected. Please subscribe to gain access.